{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T13:14:53Z","timestamp":1726492493783},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","jocn-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jocn.2018.06.004","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T08:25:45Z","timestamp":1528791945000},"page":"63-68","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The possible role of an autoimmune mechanism in the etiopathogenesis of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"54","author":[{"given":"Savvas","family":"Dalitis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Filippidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Krashias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marios","family":"Pantzaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Lambrianides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2018.06.004_b0005","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","article-title":"Alzheimer's disease and Parkinson disease","volume":"348","author":"Nussbaum","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2018.06.004_b0010","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1212\/01.wnl.0000312515.52545.51","article-title":"Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain","volume":"70","author":"Marras","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2018.06.004_b0015","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1093\/hmg\/ddp012","article-title":"Parkinson's disease: from monogenic forms to genetic susceptibility factors","volume":"18","author":"Lesage","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jocn.2018.06.004_b0020","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1289\/ehp.6361","article-title":"Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation","volume":"111","author":"Liu","year":"2003","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.jocn.2018.06.004_b0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/nyas.12820","article-title":"Mitochondrial dysfunction and Parkinson disease: a Parkin-AMPK alliance in neuroprotection","volume":"1350","author":"Hang","year":"2015","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jocn.2018.06.004_b0030","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jocn.2018.06.004_b0035","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jamda.2013.05.009","article-title":"Proinflammatory cytokines, aging, and age-related diseases","volume":"14","author":"Michaud","year":"2013","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jocn.2018.06.004_b0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nri.2016.125","article-title":"Human immune system variation","volume":"17","author":"Brodin","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jocn.2018.06.004_b0045","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1078\/0171-2985-00141","article-title":"C1q, autoimmunity and apoptosis","volume":"205","author":"Botto","year":"2002","journal-title":"Immunobiology"},{"key":"10.1016\/j.jocn.2018.06.004_b0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/1871527314666150225124928","article-title":"Inflammatory and cell death pathways in brain and peripheral blood in Parkinson's disease","volume":"14","author":"Macchi","year":"2015","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.jocn.2018.06.004_b0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.semarthrit.2006.11.003","article-title":"Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome","volume":"36","author":"Zandman-Goddard","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jocn.2018.06.004_b0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.molimm.2016.05.022","article-title":"The association between IgG and IgM antibodies against cardiolipin, beta2-glycoprotein I and Domain I of beta2-glycoprotein I with disease profile in patients with multiple sclerosis","volume":"75","author":"Filippidou","year":"2016","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jocn.2018.06.004_b0065","first-page":"13","article-title":"The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases\u20132008","volume":"10","author":"Shoenfeld","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jocn.2018.06.004_b0070","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(14)61010-2","article-title":"Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives","volume":"384","author":"Schapira","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2018.06.004_b0075","doi-asserted-by":"crossref","first-page":"33834","DOI":"10.1074\/jbc.M110.165175","article-title":"Identification of a lipid peroxidation product as the source of oxidation-specific epitopes recognized by anti-DNA autoantibodies","volume":"285","author":"Otaki","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jocn.2018.06.004_b0080","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1089\/ars.2010.3228","article-title":"Aging and immune function: molecular mechanisms to interventions","volume":"14","author":"Ponnappan","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jocn.2018.06.004_b0085","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.4049\/jimmunol.1003906","article-title":"Reactive carbonyls are a major Th2-inducing damage-associated molecular pattern generated by oxidative stress","volume":"187","author":"Moghaddam","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jocn.2018.06.004_b0090","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.4049\/jimmunol.177.3.1729","article-title":"Arginine residues are important in determining the binding of human monoclonal antiphospholipid antibodies to clinically relevant antigens","volume":"177","author":"Giles","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jocn.2018.06.004_b0095","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.molimm.2003.10.018","article-title":"Somatic mutations to Arginine residues affect the binding of human monoclonal antibodies to DNA, Histones and SmD","volume":"40","author":"Haley","year":"2003","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jocn.2018.06.004_b0100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3233\/JPD-130250","article-title":"The role of innate and adaptive immunity in Parkinson's disease","volume":"3","author":"Kannarkat","year":"2013","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.jocn.2018.06.004_b0105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-010-8242-y","article-title":"Immunology, autoimmunity, and autoantibodies in Parkinson's disease","volume":"42","author":"Benkler","year":"2012","journal-title":"Clin Rev Allerg Immunol"},{"key":"10.1016\/j.jocn.2018.06.004_b0110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.autrev.2004.03.004","article-title":"Inflamm-aging: autoimmunity, and the immune-risk phenotype","volume":"3","author":"Boren","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jocn.2018.06.004_b0115","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009365","article-title":"Programmed cell death in Parkinson's disease","volume":"2","author":"Venderova","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jocn.2018.06.004_b0120","doi-asserted-by":"crossref","first-page":"e0169755","DOI":"10.1371\/journal.pone.0169755","article-title":"Phosphatidylserine outer layer translocation is implicated in IL-10 secretion by human regulatory B cells","volume":"12","author":"Audo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jocn.2018.06.004_b0125","doi-asserted-by":"crossref","first-page":"e32383","DOI":"10.1371\/journal.pone.0032383","article-title":"Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera","volume":"7","author":"Han","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jocn.2018.06.004_b0130","first-page":"684","article-title":"Serum oxidant\/antioxidant status of patients with systemic lupus erythematosus","volume":"40","author":"Taysi","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jocn.2018.06.004_b0135","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10072-016-2782-8","article-title":"Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson's disease","volume":"38","author":"Gokce Cokal","year":"2017","journal-title":"Neurol Sci"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817321744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817321744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T06:15:32Z","timestamp":1604384132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586817321744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":27,"alternative-id":["S0967586817321744"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2018.06.004","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The possible role of an autoimmune mechanism in the etiopathogenesis of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2018.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}